Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H N Bramson

Showing results (11-20 of 18) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 18 results.
Biochemistry|August 31, 1982
A kinetic study of interactions of (Rp)- and (Sp)-adenosine cyclic 3',5'-phosphorothioates with type II bovine cardiac muscle adenosine cyclic 3',5'-phosphate dependent protein kinaseC A O'Brian, S O Roczniak, H N Bramson, et al.
Biochemistry|July 14, 1987
Conformation of Leu-Arg-Arg-Ala-Ser-Leu-Gly bound in the active site of adenosine cyclic 3',5'-phosphate dependent protein kinaseH N Bramson, N E Thomas, W T Miller, et al.
Biochemistry|July 14, 1987
Distinguishing among protein kinases by substrate specificitiesN E Thomas, H N Bramson, A C Nairn, et al.
Biochemistry|March 1, 1994
17 beta-(N-tert-butylcarbamoyl)-4-aza-5 alpha-androstan-1-en-3-one is an active site-directed slow time-dependent inhibitor of human steroid 5 alpha-reductase 1G Tian, J D Stuart, M L Moss, et al.
Journal of Medicinal Chemistry|July 7, 1995
Structure-activity relationships for inhibition of type 1 and 2 human 5 alpha-reductase and human adrenal 3 beta-hydroxy-delta 5-steroid dehydrogenase/3-keto-delta 5-steroid isomerase by 6-azaandrost-4-en-3-ones: optimization of the C17 substituentS V Frye, C D Haffner, P R Maloney, et al.
Biochemical Pharmacology|September 7, 2001
Pharmacokinetic parameters and mechanisms of inhibition of rat type 1 and 2 steroid 5alpha-reductases: determinants for different in vivo activities of GI198745 and finasteride in the ratJ D Stuart, F W Lee, D Simpson Noel, et al.
Journal of Medicinal Chemistry|December 1, 2001
Oxindole-based inhibitors of cyclin-dependent kinase 2 (CDK2): design, synthesis, enzymatic activities, and X-ray crystallographic analysisH N Bramson, J Corona, S T Davis, et al.
Science (New York, N.Y.)|January 6, 2001
Prevention of chemotherapy-induced alopecia in rats by CDK inhibitorsS T Davis, B G Benson, H N Bramson, et al.
Pageof 2

Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
Biochemistry|August 31, 1982
A kinetic study of interactions of (Rp)- and (Sp)-adenosine cyclic 3',5'-phosphorothioates with type II bovine cardiac muscle adenosine cyclic 3',5'-phosphate dependent protein kinaseC A O'Brian, S O Roczniak, H N Bramson, et al.
Biochemistry|July 14, 1987
Conformation of Leu-Arg-Arg-Ala-Ser-Leu-Gly bound in the active site of adenosine cyclic 3',5'-phosphate dependent protein kinaseH N Bramson, N E Thomas, W T Miller, et al.
Biochemistry|July 14, 1987
Distinguishing among protein kinases by substrate specificitiesN E Thomas, H N Bramson, A C Nairn, et al.
Biochemistry|March 1, 1994
17 beta-(N-tert-butylcarbamoyl)-4-aza-5 alpha-androstan-1-en-3-one is an active site-directed slow time-dependent inhibitor of human steroid 5 alpha-reductase 1G Tian, J D Stuart, M L Moss, et al.
Journal of Medicinal Chemistry|July 7, 1995
Structure-activity relationships for inhibition of type 1 and 2 human 5 alpha-reductase and human adrenal 3 beta-hydroxy-delta 5-steroid dehydrogenase/3-keto-delta 5-steroid isomerase by 6-azaandrost-4-en-3-ones: optimization of the C17 substituentS V Frye, C D Haffner, P R Maloney, et al.
Biochemical Pharmacology|September 7, 2001
Pharmacokinetic parameters and mechanisms of inhibition of rat type 1 and 2 steroid 5alpha-reductases: determinants for different in vivo activities of GI198745 and finasteride in the ratJ D Stuart, F W Lee, D Simpson Noel, et al.
Journal of Medicinal Chemistry|December 1, 2001
Oxindole-based inhibitors of cyclin-dependent kinase 2 (CDK2): design, synthesis, enzymatic activities, and X-ray crystallographic analysisH N Bramson, J Corona, S T Davis, et al.
Science (New York, N.Y.)|January 6, 2001
Prevention of chemotherapy-induced alopecia in rats by CDK inhibitorsS T Davis, B G Benson, H N Bramson, et al.
Pageof 2